Managing common endocrine disorders amid COVID-19 pandemic

Diabetes & Metabolic Syndrome
Rimesh Pal, Sanjay K Bhadada

Abstract

The novel coronavirus disease (COVID-19) pandemic and the resulting nationwide lockdowns have posed a major challenge to the management of pre-existing and newly diagnosed endocrine disorders. Herein, we have summarized the management approaches of common endocrine disorders amid the ongoing pandemic. We have performed an extensive literature search for articles in PubMed, EMBASE and Google Scholar databases till 25 May 2020, with the following keywords: "COVID-19", "diabetes mellitus", "thyroid disorders", "primary adrenal insufficiency", "Cushing's syndrome", "pituitary tumors", "vitamin D″", "osteoporosis", "primary hyperparathyroidism", "hypoparathyroidism", "management", "treatment" and "guidelines" with interposition of the Boolean operator "AND". We have summarized the most feasible strategies for the management of diabetes mellitus, thyroid disorders, primary adrenal insufficiency (including congenital adrenal hyperplasia), Cushing's syndrome, pituitary tumors, osteoporosis, primary hyperparathyroidism and hypoparathyroidism amid the constraints laid down by the raging pandemic. In general, medical management should be encouraged and surgical interventions should be deferred whenever possible. Ongoing medications should...Continue Reading

Citations

Dec 22, 2020·Heliyon·Kanchan KumariUmakanta Subudhi
Feb 14, 2021·Diabetes & Metabolic Syndrome·Yashdeep GuptaNikhil Tandon
Feb 28, 2021·Archives of Osteoporosis·Roland KocijanJochen Zwerina
Mar 3, 2021·Clinical Endocrinology·Dorota DworakowskaAshley B Grossman
Jun 16, 2021·Journal of Bone Metabolism·Sung Hye KongByung-Ho Yoon

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addison Disease

Addison's disease, also known as primary adrenal insufficiency and hypocortisolism, is a long-term endocrine disorder in which the adrenal glands do not produce enough steroid hormones. Discover the latest research on Addison's disease here.

© 2022 Meta ULC. All rights reserved